Key result
The abstract is truncated and does not report the quantitative results of Diamox administration in the 26 patients with severe congestive heart failure.
Why the study?
Does oral administration of a carbonic anhydrase inhibitor (Diamox) improve clinical efficacy as a diuretic in patients with severe congestive heart failure?
Population
26 patients with severe congestive heart failure
Design
Case_series
Authors
Loading...
May support Diamox as adjunctive diuretic in refractory cases; leaves open efficacy and safety for modern practice.
Does oral administration of a carbonic anhydrase inhibitor (Diamox) improve clinical efficacy as a diuretic in patients with severe congestive heart failure?
This study aimed to evaluate the clinical efficacy of the carbonic anhydrase inhibitor Diamox as a diuretic in patients with severe congestive heart failure.
Relman et al. (1954) studied severe congestive heart failure (n=26). Diamox (carbonic anhydrase inhibitor) was evaluated. The abstract is truncated and does not report the quantitative results of Diamox administration in the 26 patients with severe congestive heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: